FULC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,831.36

Fulcrum Therapeutics Insider Trading History Chart

Fulcrum Therapeutics Share Price & Price History

^$3.12

▲ +0.22 (7.59%)

As of 03/14/2025 05:00 PM ET

Days: 30 | 90 | 365

Fulcrum Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/7/2024	Greg Tourangeau	Insider	Sell	236	$7.76	$1,831.36	11,571
3/8/2024	Greg Tourangeau	VP	Sell	4,884	$11.72	$57,240.48	11,807
5/10/2023	Greg Tourangeau	Insider	Sell	210	$3.31	$695.10	15,992
1/20/2023	Ra Capital Management, L.P.	Major Shareholder	Buy	1,923,076	$13.00	$24,999,988.00	11,609,704
1/13/2023	Robert J. Gould	CEO	Sell	6,766	$15.00	$101,490.00	499,864
1/4/2023	Ra Capital Management, L.P.	Major Shareholder	Buy	180,703	$7.28	$1,315,517.84	9,686,628
12/27/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	4,089	$5.99	$24,493.11	9,505,925
12/19/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	98,787	$5.90	$582,843.30	9,501,836
12/16/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	1,341,420	$5.42	$7,270,496.40	9,403,049
12/14/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	824,600	$5.46	$4,502,316.00	7,824,600
6/6/2022	Robert J. Gould	Director	Sell	24,382	$8.10	$197,494.20	506,630
6/3/2022	Robert J. Gould	Director	Sell	25,551	$7.95	$203,130.45	506,630
4/7/2022	Robert J. Gould	Director	Sell	5,631	$24.02	$135,256.62	506,630
4/4/2022	Robert J. Gould	Director	Sell	7,235	$24.02	$173,784.70	506,630
4/1/2022	Robert J. Gould	Director	Sell	34,464	$24.03	$828,169.92	506,630

SEC Filings (Institutional Ownership Changes) for Fulcrum Therapeutics (NASDAQ:FULC)

89.83% of Fulcrum Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Fulcrum Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/20/2025	Mackenzie Financial Corp	118,025	$0.56M	0.0%	+412.5%	0.219%
2/17/2025	Woodline Partners LP	1,410,520	$6.63M	0.0%	+110.3%	2.615%
2/17/2025	Two Sigma Investments LP	169,542	$0.80M	0.0%	-37.7%	0.314%
2/17/2025	Two Sigma Advisers LP	343,600	$1.62M	0.0%	-10.1%	0.637%
2/17/2025	Suvretta Capital Management LLC	3,338,466	$15.69M	0.5%	+182.3%	6.189%
2/17/2025	Shay Capital LLC	301,464	$1.42M	0.2%	+4.2%	0.559%
2/17/2025	Sherbrooke Park Advisers LLC	45,157	$0.21M	0.1%	-80.1%	0.084%
2/17/2025	Millennium Management LLC	76,123	$0.36M	0.0%	+224.0%	0.141%
2/17/2025	LMR Partners LLP	112,500	$0.53M	0.0%	-367.2%	0.209%
2/17/2025	J. Goldman & Co LP	20,250	$95K	0.0%	-57.2%	0.038%
2/17/2025	Graham Capital Management L.P.	144,942	$0.68M	0.0%	+58.9%	0.269%
2/17/2025	D. E. Shaw & Co. Inc.	583,203	$2.74M	0.0%	-23.0%	1.081%
2/17/2025	Corton Capital Inc.	23,498	$0.11M	0.1%	-59.2%	0.044%
2/17/2025	Bridgeway Capital Management LLC	140,000	$0.66M	0.0%	N/A	0.260%
2/17/2025	Cantor Fitzgerald L. P.	20,000	$94K	0.0%	N/A	0.037%
2/17/2025	Bank of America Corp DE	91,866	$0.43M	0.0%	-8.1%	0.170%
2/17/2025	BNP Paribas Financial Markets	8,014	$38K	0.0%	N/A	0.015%
2/17/2025	Algert Global LLC	34,117	$0.16M	0.0%	-14.0%	0.063%
2/14/2025	Northern Trust Corp	710,321	$3.34M	0.0%	+25.1%	1.317%
2/14/2025	Boothbay Fund Management LLC	59,533	$0.28M	0.0%	-60.6%	0.110%
2/14/2025	Susquehanna Fundamental Investments LLC	213,213	$1M	0.0%	N/A	0.395%
2/14/2025	Nebula Research & Development LLC	75,140	$0.35M	0.0%	-8.1%	0.139%
2/14/2025	Adage Capital Partners GP L.L.C.	3,000,000	$14.10M	0.0%	+50.0%	5.562%
2/14/2025	RBF Capital LLC	80,506	$0.38M	0.0%	-24.1%	0.149%
2/14/2025	Price T Rowe Associates Inc. MD	52,368	$0.25M	0.0%	+46.6%	0.097%
2/14/2025	Hsbc Holdings PLC	75,959	$0.36M	0.0%	+55.0%	0.141%
2/14/2025	MetLife Investment Management LLC	40,107	$0.19M	0.0%	+145.8%	0.074%
2/14/2025	MYDA Advisors LLC	63,970	$0.30M	0.1%	N/A	0.119%
2/14/2025	Dimensional Fund Advisors LP	1,418,690	$6.67M	0.0%	-0.3%	2.630%
2/14/2025	Altium Capital Management LLC	111,812	$0.53M	0.1%	N/A	0.207%
2/13/2025	Zacks Investment Management	20,999	$99K	0.0%	N/A	0.039%
2/13/2025	Mariner LLC	16,516	$78K	0.0%	N/A	0.031%
2/13/2025	ADAR1 Capital Management LLC	196,248	$0.92M	0.2%	+177.2%	0.364%
2/13/2025	Wells Fargo & Company MN	34,264	$0.16M	0.0%	+34.4%	0.064%
2/12/2025	Geode Capital Management LLC	1,294,515	$6.09M	0.0%	-2.0%	2.400%
2/12/2025	Wellington Management Group LLP	172,158	$0.81M	0.0%	-2.3%	0.319%
2/12/2025	WINTON GROUP Ltd	12,997	$61K	0.0%	-70.6%	0.024%
2/11/2025	Simplify Asset Management Inc.	80,714	$0.38M	0.0%	-77.0%	0.150%
2/11/2025	American Century Companies Inc.	120,611	$0.57M	0.0%	+5.9%	0.224%
2/11/2025	Intech Investment Management LLC	30,499	$0.14M	0.0%	+74.9%	0.057%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	367,594	$1.73M	0.0%	+176.8%	0.681%
2/6/2025	Charles Schwab Investment Management Inc.	526,045	$2.47M	0.0%	-7.6%	0.975%
2/5/2025	Bailard Inc.	35,900	$0.17M	0.0%	N/A	0.067%
2/4/2025	Bank of New York Mellon Corp	141,873	$0.67M	0.0%	+2.3%	0.263%
1/24/2025	Matisse Capital	128,445	$0.60M	0.3%	+20.4%	0.238%
1/17/2025	SG Americas Securities LLC	30,442	$0.14M	0.0%	-7.8%	0.056%
11/19/2024	Barclays PLC	124,141	$0.44M	0.0%	+367.1%	0.230%
11/16/2024	Geode Capital Management LLC	1,320,862	$4.72M	0.0%	+1.0%	2.117%
11/15/2024	Barclays PLC	124,141	$0.44M	0.0%	+367.1%	0.199%
11/15/2024	Y Intercept Hong Kong Ltd	71,103	$0.25M	0.0%	N/A	0.114%
11/15/2024	Wellington Management Group LLP	176,161	$0.63M	0.0%	-3.6%	0.282%
11/15/2024	State Street Corp	1,680,229	$6M	0.0%	+61.4%	2.693%
11/15/2024	Stifel Financial Corp	25,025	$89K	0.0%	-71.4%	0.040%
11/15/2024	RA Capital Management L.P.	10,229,099	$36.52M	0.4%	-11.9%	16.393%
11/15/2024	RBF Capital LLC	106,128	$0.38M	0.0%	-15.1%	0.170%
11/15/2024	Jacobs Levy Equity Management Inc.	202,030	$0.72M	0.0%	N/A	0.324%
11/15/2024	Centiva Capital LP	76,577	$0.27M	0.0%	N/A	0.123%
11/14/2024	Braidwell LP	1,069,158	$3.82M	0.1%	N/A	1.713%
11/14/2024	Verition Fund Management LLC	37,643	$0.13M	0.0%	N/A	0.060%
11/14/2024	Walleye Capital LLC	16,554	$59K	0.0%	N/A	0.027%
11/14/2024	Suvretta Capital Management LLC	1,182,791	$4.22M	0.1%	-53.5%	1.895%
11/13/2024	FMR LLC	1,724,015	$6.16M	0.0%	-67.7%	2.763%
11/12/2024	Charles Schwab Investment Management Inc.	569,185	$2.03M	0.0%	+223.4%	0.912%
11/9/2024	Intech Investment Management LLC	17,442	$62K	0.0%	N/A	0.028%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	132,784	$0.47M	0.0%	N/A	0.213%
11/6/2024	Simplify Asset Management Inc.	351,314	$1.25M	0.1%	-47.9%	0.563%
11/5/2024	GSA Capital Partners LLP	17,142	$61K	0.0%	-87.3%	0.027%
10/25/2024	China Universal Asset Management Co. Ltd.	12,002	$43K	0.0%	+64.4%	0.019%
10/23/2024	Assenagon Asset Management S.A.	340,495	$1.22M	0.0%	-31.6%	0.548%
10/3/2024	SG Americas Securities LLC	33,019	$0.12M	0.0%	+26.5%	0.053%
8/16/2024	Algert Global LLC	41,303	$0.26M	0.0%	+202.1%	0.066%
8/15/2024	Susquehanna Portfolio Strategies LLC	81,217	$0.50M	0.0%	-51.9%	0.131%
8/15/2024	The Manufacturers Life Insurance Company	24,480	$0.15M	0.0%	N/A	0.039%
8/15/2024	Caxton Associates LP	18,875	$0.12M	0.0%	N/A	0.030%
8/14/2024	Marshall Wace LLP	333,161	$2.07M	0.0%	+47.7%	0.536%
8/14/2024	Profund Advisors LLC	10,921	$68K	0.0%	N/A	0.018%
8/13/2024	Simplify Asset Management Inc.	674,832	$4.18M	0.3%	-0.2%	1.086%
8/12/2024	Marathon Trading Investment Management LLC	10,800	$67K	0.0%	-76.0%	0.017%
8/9/2024	Renaissance Technologies LLC	13,257	$82K	0.0%	N/A	0.021%
8/9/2024	Dimensional Fund Advisors LP	1,480,926	$9.18M	0.0%	+13.5%	2.383%
8/8/2024	American Century Companies Inc.	104,371	$0.65M	0.0%	+13.2%	0.168%
8/6/2024	Quest Partners LLC	26,164	$0.16M	0.0%	N/A	0.042%
8/6/2024	Los Angeles Capital Management LLC	21,038	$0.13M	0.0%	N/A	0.034%
8/3/2024	National Bank of Canada FI	4,460	$28K	0.0%	+869.6%	0.007%
8/1/2024	Rhumbline Advisers	91,432	$0.57M	0.0%	+5,417.9%	0.147%
7/26/2024	Bank of New York Mellon Corp	186,727	$1.16M	0.0%	N/A	0.300%
7/18/2024	Assenagon Asset Management S.A.	497,456	$3.08M	0.0%	N/A	0.800%
7/12/2024	SG Americas Securities LLC	26,093	$0.16M	0.0%	+113.8%	0.042%
5/16/2024	Jane Street Group LLC	535,062	$5.05M	0.0%	+54.3%	0.861%
5/16/2024	Jacobs Levy Equity Management Inc.	20,472	$0.19M	0.0%	-83.2%	0.033%
5/14/2024	StemPoint Capital LP	407,108	$3.84M	1.0%	+8.1%	0.655%
5/10/2024	Vanguard Group Inc.	2,538,665	$23.97M	0.0%	+0.7%	4.084%
5/7/2024	SG Americas Securities LLC	12,206	$0.12M	0.0%	N/A	0.020%
5/7/2024	Marquette Asset Management LLC	6,039	$57K	0.0%	-78.3%	0.010%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	32,591	$0.31M	0.0%	N/A	0.052%
4/30/2024	Commonwealth Equity Services LLC	83,428	$0.79M	0.0%	-13.5%	0.134%
4/29/2024	Principal Financial Group Inc.	16,233	$0.15M	0.0%	-9.8%	0.026%
4/29/2024	China Universal Asset Management Co. Ltd.	11,916	$0.11M	0.0%	+66.7%	0.019%
4/19/2024	Denali Advisors LLC	27,100	$0.26M	0.1%	-53.1%	0.044%
4/4/2024	Mass General Brigham Inc	205,356	$1.94M	3.4%	N/A	0.332%

Data available starting January 2016

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy is under phase III clinical trial; and pociredir, a fetal hemoglobin inducer for the treatment of sickle cell disease and beta-thalassemia is under phase I clinical trial. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has collaboration and license agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and MyoKardia, Inc. to discover and develop therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $3.12

$2.87

$3.21

50 Day Range

MA: $3.78

$2.90

$4.92

52 Week Range

Now: $3.12

$2.78

$11.48

Volume

733,972 shs

Average Volume

467,322 shs

Market Capitalization

$168.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.2

Who are the company insiders with the largest holdings of Fulcrum Therapeutics?: Fulcrum Therapeutics' top insider investors include:
Greg Tourangeau (Insider)
Greg Tourangeau (VP)
Learn More about top insider investors at Fulcrum Therapeutics.
Who are the major institutional investors of Fulcrum Therapeutics?: Fulcrum Therapeutics' top institutional shareholders include:
Suvretta Capital Management LLC — 6.19%
Adage Capital Partners GP L.L.C. — 5.56%
Dimensional Fund Advisors LP — 2.63%
Woodline Partners LP — 2.61%
Geode Capital Management LLC — 2.40%
Northern Trust Corp — 1.32%
Learn More about top institutional investors of Fulcrum Therapeutics stock.
Which major investors are selling Fulcrum Therapeutics stock?: Within the previous quarter, FULC stock was sold by these institutional investors:
Simplify Asset Management Inc.
Citadel Advisors LLC
Simplex Trading LLC
Sherbrooke Park Advisers LLC
D. E. Shaw & Co. Inc.
Two Sigma Investments LP
Boothbay Fund Management LLC
Group One Trading LLC
Which major investors are buying Fulcrum Therapeutics stock?: During the previous quarter, FULC stock was purchased by institutional investors including:
Suvretta Capital Management LLC
Adage Capital Partners GP L.L.C.
Woodline Partners LP
Connor Clark & Lunn Investment Management Ltd.
Susquehanna Fundamental Investments LLC
LMR Partners LLP
Northern Trust Corp
Bridgeway Capital Management LLC